Lv1
40 积分 2025-05-12 加入
Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
2天前
已完结
IP38-23 GLP-1 RECEPTOR AGONISTS REDUCE MORTALITY AND HOSPITALIZATION IN DIABETIC PATIENTS WITH UROLOGIC MALIGNANCIES: A RETROSPECTIVE COHORT STUDY
7天前
已完结
GLP-1 Receptor Agonists and Breast Cancer Survivorship: Weight Management, Metabolic Health, and Oncologic Safety
7天前
已完结
Incidence of hematologic malignancies and mortality associated with GLP-1 receptor agonist and SGLT2 inhibitor use in type 2 diabetes mellitus: results of a retrospective cohort study of electronic health records
7天前
已完结
Association of GLP-1 receptor agonist use with overall survival in patients with colorectal cancer and type 2 diabetes: A multicenter real-world study
7天前
已关闭
Impact of GLP-1 receptor agonists on outcomes in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: A multicenter propensity-matched real-world analysis
7天前
已关闭
Glucagon-like peptide-1 receptor agonist use in lung cancer patients receiving immune checkpoint inhibitors: A real-world study
7天前
已关闭
Exposure to GLP-1RA and Risk of Structural Progression in Differentiated Thyroid Cancer
7天前
已完结
Real‐World Cardiovascular Outcomes of GLP‐1 Receptor Agonists in Women With Type 2 Diabetes and Breast Cancer
14天前
已关闭
皖公网安备34019202002308
